Coverage guides for every major treatment — GLP-1 medications, peptides, fertility, mental health, and more. Each guide covers approval rates by insurer, prior auth requirements, and cash-pay alternatives.
Coverage for diabetes and weight loss. BCBS approves 78% of qualifying cases.
FDA-approved for weight management. Coverage improving in 2026.
Dual GIP/GLP-1 agonist. Higher efficacy, stricter coverage criteria.
Rarely covered by insurance. Cash-pay from $150/mo via 503B pharmacies.
Tissue repair and recovery peptides. Almost never covered — cash-pay only.
TRT coverage varies widely. Medically diagnosed hypogonadism usually covered.
Growth hormone secretagogues. Rarely covered but available via telehealth.
Coverage data is based on publicly available formulary information as of 2026. Always verify with your insurer.